The study aims to establish a cohort of patients with type 2 diabetes (T2D) who have achieved remission through lifestyle intervention or bariatric surgery. Remission is defined as a return of HbA1c to less than 6.5% that occurs spontaneously or following an intervention and in the absence of usual glucose-lowering pharmacotherapy for at least 3 months.
Eligibility
Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Have previously been diagnosed with T2D;
2. Have achieved diabetes remission (HbA1c below 6.5% and no glucose-lowering medications for at least 3 months) through lifestyle intervention and bariatric surgery.
Exclusion Criteria:
1. Have not been diagnosed with T2D;
2. Have an HbA1c level higher than 6.5%;
3. Are taking any glucose-lowering medications;
4. Are ongoing medical treatment for diseases such as cancer, auto-immune or inflammatory disease, liver or kidney disorders;
5. Are unable to follow remote guidance by internet or smartphone;
6. Are unable to read or communicate in English.
Primary outcome measure(s)
Establish a cohort of participants who achieved T2D remission through lifestyle interventions — Baseline and after 1 year. Establish a cohort of participants who achieved T2D remission through lifestyle interventions.
Establish a cohort of participants who achieved T2D remission through bariatric surgery — Baseline and after 1 year. Establish a cohort of participants who achieved T2D remission through bariatric surgery.
Trial sites (1)
Facility
City
Region
Status
University of British Columbia Okanagan
Kelowna
British Columbia
More University of British Columbia trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
